Annual Results Results Snapshot
Figures in Million
Consolidate Annual Results
Mar'22
Mar'21
Mar'20
Mar'19
Mar'18
Mar'17
Mar'16
Net Sales
37.56
18.29
16.61
8.88
6.15
3.08
2.45
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
37.56
18.29
16.61
8.88
6.15
3.08
2.45
Raw Material Cost
20.79
10.16
8.48
4.27
2.97
1.80
1.75
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
12.33
8.91
7.06
4.58
4.99
3.74
2.24
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
0.66
0.30
0.16
1.21
0.98
0.29
0.10
Selling and Distribution Expenses
16.50
14.11
10.68
9.08
9.23
8.18
6.29
Other Expenses
-1.12
-0.88
-0.67
-0.51
-0.55
-0.32
-0.14
Total Expenditure (Excl Depreciation)
39.06
24.67
19.68
14.05
12.70
10.79
8.94
Operating Profit (PBDIT) excl Other Income
-1.5
-6.4
-3.1
-5.2
-6.6000000000000005
-7.7
-6.5
Other Income
0.01
0.06
0.06
0.06
0.07
0.04
0.01
Operating Profit (PBDIT)
3.10
-3.08
-0.91
-4.00
-5.28
-6.94
-5.92
Interest
0.66
0.30
0.16
1.21
0.98
0.29
0.10
Exceptional Items
-1.04
-5.46
-0.77
9.23
-2.70
-0.69
-5.83
Gross Profit (PBDT)
16.78
8.13
8.13
4.61
3.17
1.28
0.70
Depreciation
4.59
3.25
2.09
1.10
1.20
0.74
0.56
Profit Before Tax
-3.19
-12.09
-3.94
2.92
-10.17
-8.66
-12.41
Tax
-1.27
0.10
-1.51
-0.47
-0.68
-0.80
-0.33
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
-1.92
-12.18
-2.43
3.39
-9.48
-7.86
-12.08
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
-1.92
-12.18
-2.43
3.39
-9.48
-7.86
-12.08
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
-1.92
-12.18
-2.43
3.39
-9.48
-7.86
-12.08
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
0.0
0.0
0.0
0.0
0.0
0.0
0.1
Reserves
32.74
32.92
26.30
10.70
-2.60
5.84
1.49
Earnings per share (EPS)
-0.0
-0.02
-0.0
0.01
-0.03
-0.03
-0.06
Diluted Earnings per share
-0.0
-0.02
-0.0
0.01
-0.03
-0.03
-0.06
Operating Profit Margin (Excl OI)
-4.0%
-34.91%
-18.47%
-58.14%
-106.66%
-250.52%
-264.72%
Gross Profit Margin
3.72%
-48.34%
-11.13%
45.21%
-145.85%
-257.23%
-483.34%
PAT Margin
-5.1%
-66.62%
-14.65%
38.16%
-154.27%
-255.27%
-492.46%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Annual Analysis Highlights
Net Sales
YoY Growth in year ended Mar 2022 is 105.46% vs 10.24% in Mar 2021
Consolidate Net Profit
YoY Growth in year ended Mar 2022 is 84.43% vs -408.33% in Mar 2021
Operating Profit (PBDIT) excl Other Income
YoY Growth in year ended Mar 2022 is 200.00% vs -210.00% in Mar 2021
Interest
YoY Growth in year ended Mar 2022 is 133.33% vs 50.00% in Mar 2021
Operating Profit Margin (Excl OI)
YoY Growth in year ended Mar 2022 has improved from Mar 2021
Compare Annual Results Of Yourgene Health Plc With
Figures in Million
Consolidate Annual Results
Change(GBP)
Change(%)
Net Sales
37.56
5.03
32.53
646.72%
Other Operating Income
0.00
0.00
0.00
Total Operating income
37.56
5.03
32.53
646.72%
Raw Material Cost
20.79
3.38
17.41
515.09%
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
12.33
3.35
8.98
268.06%
Power Cost
0
0
0.00
Manufacturing Expenses
0.66
0.80
-0.14
-17.50%
Selling and Distribution Expenses
16.50
2.48
14.02
565.32%
Other Expenses
-1.12
-0.35
-0.77
-220.00%
Total Expenditure (Excl Depreciation)
39.06
6.50
32.56
500.92%
Operating Profit (PBDIT) excl Other Income
-1.50
-1.47
-0.03
-2.04%
Other Income
0.01
-0.15
0.16
106.67%
Operating Profit (PBDIT)
3.10
-1.14
4.24
371.93%
Interest
0.66
0.80
-0.14
-17.50%
Exceptional Items
-1.04
0.00
-1.04
Gross Profit (PBDT)
16.78
1.65
15.13
916.97%
Depreciation
4.59
0.48
4.11
856.25%
Profit Before Tax
-3.19
-2.42
-0.77
-31.82%
Tax
-1.27
0.03
-1.30
-4,333.33%
Provisions and contingencies
0.00
0
0.00
Profit After Tax
-1.92
-2.44
0.52
21.31%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
-1.92
-2.44
0.52
21.31%
Share in Profit of Associates
0.00
0
0.00
Minority Interest
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
Consolidated Net Profit
-1.92
-2.44
0.52
21.31%
Equity Capital
0
0
0.00
Face Value
0.00
0.01
0.00
Reserves
32.74
-3.07
35.81
1,166.45%
Earnings per share (EPS)
-0.00
-0.01
0.01
100.00%
Diluted Earnings per share
-0.00
-0.01
0.01
100.00%
Operating Profit Margin (Excl OI)
-4.00%
-29.24%
0.00
25.24%
Gross Profit Margin
3.72%
-38.46%
0.00
42.18%
PAT Margin
-5.10%
-48.59%
0.00
43.49%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Annual - Net Sales
Net Sales 3.76 Million
in Mar 2022Figures in Million
YoY Growth in year ended Mar 2022 is 105.46% vs 10.24% in Mar 2021
Annual - Consolidate Net Profit
Consolidate Net Profit -0.19 Million
in Mar 2022Figures in Million
YoY Growth in year ended Mar 2022 is 84.43% vs -408.33% in Mar 2021
Annual - Operating Profit (PBDIT)
Operating Profit (PBDIT) 0.31 Million
in Mar 2022Figures in Million
YoY Growth in year ended Mar 2022 is 200.00% vs -210.00% in Mar 2021
Annual - Interest
Interest 0.07 Million
in Mar 2022Figures in Million
YoY Growth in year ended Mar 2022 is 133.33% vs 50.00% in Mar 2021
Annual - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) -4.00%
in Mar 2022Figures in %
YoY Growth in year ended Mar 2022 has improved from Mar 2021
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
